- No public price.
- Attested
- Type II
- —
- —
- US


CalmWave
by CalmWave Inc. · US
AI tool that recommends patient-specific vital-sign alarm limits for ICU staff. Authorized clinical leaders approve every change.
On this page
Not rated: too little independent evidence yet.
- Regulatory & Compliance10/22
HIPAA + (SOC2 or BAA) attested
- Clinical Integration0/11.6
No EHR integrations listed
- Evidence Strength0/30
No peer-reviewed coverage
- Vendor & Market3/18
Seed-stage or unfunded
- Sentiment & Transparency1.3/2.5
Pricing on request, no public amounts
▸ Show all 11 dimensions▾ Hide dimension detail
- FDA clearance0/12
No FDA clearance listed
- HIPAA / SOC2 / BAA10/10
HIPAA + (SOC2 or BAA) attested
- EHR integrations (count)0/6
No EHR integrations listed
- Top-3 EHR coverage (Epic / Oracle / Athena)0/5
None of the top-3 EHRs covered
- Bidirectional write-back0/1
No bidirectional write-back documented
- Peer-reviewed papers0/21
No peer-reviewed coverage
- RCT / meta-analysis / systematic review0/9
No RCT, meta-analysis, or systematic review
- Funding & adoption signal3/12
Seed-stage or unfunded
- Years in market0/6
Founded year not recorded
- Pricing transparency1/3
Pricing on request, no public amounts
AI tool that recommends patient-specific vital-sign alarm limits for ICU staff. Authorized clinical leaders approve every change.
No public price. HIPAA + SOC 2 Type II attested.
Evidence record
No FDA decision cited in our research as of November 2, 2026.
- Score computed November 2, 2026, method 1.2.0
- Review written November 2, 2026
MedAI Verdict, CalmWave record, https://medaiverdict.com/tools/calmwave, version November 2, 2026
Bottom line
The vendor says bedside monitors raise many non-actionable alarms, and its software recommends patient-specific limits to reduce them. The Seattle company frames the product as "The Data Foundation For Safer Patient Care", with a platform called Tessera. It suits an ICU whose nursing and clinical engineering leaders want to adjust alarm limits and have an authorized clinical lead approve each change. The outcome figures are the vendor's, so a hospital that needs peer-reviewed evidence before touching alarm settings has none to read for this product.
How does the vendor say it works?
According to the vendor's transparency page, a recommendation appears only when five conditions hold. Vitals are stable, there has been no recent medication or intervention, no threshold change in the past three hours, at least three alarms in the last 15 minutes, and no outlier trends.
The vendor lists structured inputs such as vitals, staffing, EHR activity and alarm frequency and calls the output "not generative predictions", without naming the model type. It says patient data is de-identified during training and that final decisions stay with human experts. Only authorized clinical leaders approve changes, and the explanation for a recommendation can be reviewed in under 10 seconds, it says. It also describes an audit trail, a longitudinal patient record and detection of unsafe device configurations. The vendor cites "U.S. and international patents" without numbers.
What results does it report?
The homepage reports 47% fewer non-actionable alarms, 10 fewer hours of alarm exposure per patient stay and 2 to 4 nursing hours reclaimed per shift, with no methodology. A case study with Wellstar Health System is published by the vendor. No peer-reviewed study of CalmWave is known.
Company and customers
CalmWave Inc. is at 2801 Alaskan Way, Seattle, and Ophir Ronen is founder and CEO. Investor logos on the homepage include Bonfire Ventures, Tau Ventures, Rebellion Ventures and Catalyst by Wellstar, with no amounts. Catalyst by Wellstar is both an investor and part of the named customer group, which also includes Wellstar Health System and Wellstar Cobb Medical Center.
The vendor says it works with hospital middleware, monitoring platforms and EHRs from several vendors and names none. It lists SOC 2 Type II and HIPAA and claims Joint Commission alignment as a benefit. Its regulatory page makes no FDA claim, and the footer states the product "does not cure, mitigate, treat, or prevent disease". Whether it treats threshold recommendations as non-device decision support is left unsaid.
Pricing
The vendor shows no price and routes enquiries through a demo request.
The verdict
In the workflow the vendor describes, software proposes and an authorized clinical leader decides. A unit that wants that division of labor matches it, while a unit looking for a study to cite before changing limits has only the vendor's figures.
Editorial review last generated November 2, 2026. Synthesized from clinician sentiment, peer-reviewed coverage, and our editorial silo picks. Refined by hand where vendor facts change.
What it costs
All tiers are custom-quoted. The vendor does not publish per-provider list pricing.
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | Not stated | Not stated | No public price. |
Source: vendor pricing page. Last checked November 2, 2026.
What deploys cleanly
Carries SOC 2 Type II, HIPAA per vendor documentation. Independent attestation review is the buyer's responsibility before clinical deployment.

